Skip to content
★ Sign in to follow
BD

Bassam Damaj

Seelos Therapeutics, Inc.Innovus Pharmaceuticals, Inc.
Total declarations
20
Companies
2
▲ Purchases (6 ops.)
€281k
▼ Sales (0 ops.)
—

Latest filing published 29 Jun 2015 for INNOVUS PHARMACEUTICALS, INC., €5.

Insider track record

Disclosed buys
6
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
6

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Bassam Damaj: trading record in brief

This profile gathers the share dealings of Bassam Damaj across 2 companies, led by Seelos Therapeutics, Inc. and Innovus Pharmaceuticals, Inc. The record holds 20 filings, for trades running from 11 January 2010 to 26 June 2015.

The open-market record is one-sided, with 6 purchases worth €281k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 9 share grants.

In size, the median ticket on the buying side is €50k.

The record was last updated on 29 June 2015 with a share grant (€5) in Innovus Pharmaceuticals, Inc. The last purchase on record was published on 14 June 2013, which is 4,895 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Bassam Damaj

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total

19 of 19 declarations